JNK and IKKβ phosphorylation is reduced by glucocorticoids in adipose tissue from insulin-resistant rats

Katia Motta1, Amanda Marreiro Barbosa2, Franciane Bobinski3

  • 1Multicenter Graduate Program in Physiological Sciences, Center of Biological Sciences, Federal University of Santa Catarina (UFSC), Florianópolis, Brazil.

Abstract

Insights

Dexamethasone treatment induced insulin resistance in rats, characterized by impaired protein kinase B (PKB) and insulin receptor substrate-1 (IRS-1) activity in adipose tissue. This occurred without increasing pro-inflammatory signaling pathways.

Area of Science:

  • Endocrinology
  • Metabolic Research
  • Molecular Biology

Background:

  • Peripheral insulin resistance (IR) is a significant side effect of glucocorticoid (GC) therapies.
  • The precise molecular mechanisms underlying GC-induced IR remain incompletely understood.

Purpose of the Study:

  • To investigate the impact of dexamethasone administration on key insulin and inflammatory signaling components within rat adipose tissue.
  • To elucidate the molecular pathways contributing to dexamethasone-induced insulin resistance.

Main Methods:

  • Male Wistar rats were administered daily intraperitoneal injections of dexamethasone (1mg/kg b.w.) or saline for 5 days.
  • Metabolic status was assessed, and epididymal fat tissue was collected for lipolysis and Western blot analyses to examine protein phosphorylation and content.

Main Results:

  • Dexamethasone-treated rats exhibited hyperglycemia, hyperinsulinemia, insulin resistance, and glucose intolerance compared to controls.
  • Adipose tissue showed decreased protein kinase B (PKB) phosphorylation and increased insulin receptor substrate-1 (IRS-1) phosphorylation at inhibitory sites.
  • Despite IR, basal phosphorylation of pro-inflammatory markers c-jun-N-terminal kinase (JNK) and inhibitor of nuclear factor kappa-B (IKKβ) was reduced, alongside decreased glucocorticoid receptor (GR) protein content.

Conclusions:

  • Dexamethasone-induced insulin resistance in rats involves attenuated PKB and IRS-1 activity in epididymal fat.
  • The development of insulin resistance under these conditions did not involve increased phosphorylation of pro-inflammatory JNK and IKKβ signaling pathways.

Related Concept Videos

Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
2.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.4K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
9.7K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
6.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K